News

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...
A team based at the University of Manchester, funded by Cancer Research UK, are designing a clinical trial involving tens of ...